VYLDA D 5/100 Tablet 10’s

Description

VYLDA D 5/100 Tablet is a combination medicine used to help improve blood sugar control in people with type 2 diabetes mellitus. it combines two different glucose-lowering medicines that work through separate mechanisms, which can provide more complete blood sugar management than either medicine alone in some patients. this combination is generally used along with a healthy diet, regular physical activity, weight management when needed, and ongoing monitoring of blood glucose as advised by a healthcare professional.

dapagliflozin belongs to a group of medicines that help the kidneys remove excess sugar from the body through the urine. by increasing the amount of glucose excreted by the kidneys, it lowers blood glucose levels in a way that does not depend on insulin. vildagliptin works differently: it helps the body increase insulin release after meals and reduces the amount of sugar released by the liver by preserving the action of naturally occurring hormones called incretins. because the two ingredients act by different pathways, they may complement each other in controlling fasting and post-meal blood sugar levels.

this medicine is primarily intended for adults with type 2 diabetes when lifestyle measures alone are not enough, or when a healthcare professional feels that a combination approach is appropriate. it is not used for type 1 diabetes or for the treatment of diabetic ketoacidosis. it is important to understand that VYLDA D 5/100 Tablet helps manage blood sugar, but it does not cure diabetes. good results depend on regular use, healthy habits, and follow-up with a clinician for blood sugar checks and safety monitoring.

in some people, this medicine may also be considered when one medicine is not enough to reach target glucose goals, or when a person may benefit from avoiding medicines that commonly cause weight gain or low blood sugar. however, suitability depends on kidney function, overall health, current medicines, and the person’s diabetes history. a doctor or pharmacist should always review whether this combination is appropriate for each individual.

ingredients

• dapagliflozin: dapagliflozin is an sglt2 inhibitor that acts on the kidneys to reduce reabsorption of glucose, causing excess sugar to pass into the urine. this helps lower blood glucose levels and may also contribute to modest weight reduction and mild blood pressure lowering in some patients. it is effective only when the kidneys are able to filter and excrete glucose normally, so kidney function is an important consideration.
• vildagliptin: vildagliptin is a dpp-4 inhibitor that helps preserve incretin hormones, especially glp-1 and gip. these hormones increase insulin release when blood sugar is high and reduce glucagon release, which helps the liver produce less glucose. its effect is glucose-dependent, meaning it is less likely to cause low blood sugar when used alone, though risk can increase when combined with other diabetes medicines.
• inactive ingredients: the exact inactive ingredients can vary by manufacturer and formulation. these may include tablet-binding agents, fillers, disintegrants, coatings, and stabilizers that help maintain the tablet’s strength, stability, and swallowing properties. patients with allergies or sensitivities should check the product label or ask a pharmacist for the full formulation.

key uses

• type 2 diabetes mellitus: this combination is used to improve glycemic control in adults with type 2 diabetes when diet, exercise, and single-agent therapy are not enough. it helps lower fasting and post-meal blood sugar levels as part of a long-term diabetes management plan.
• combination therapy when dual mechanism is needed: it may be prescribed when a healthcare professional wants to use two complementary approaches at once, especially if blood sugar remains above target on one medicine alone. the dual action can help simplify treatment compared with taking the two medicines separately.
• support for better overall glucose control: by reducing glucose production and enhancing glucose removal, this medicine can help improve daily blood sugar patterns. better glucose control may lower the risk of diabetes-related complications over time, although this depends on consistent treatment and regular medical care.
• use as part of a comprehensive diabetes plan: the medicine is meant to be used together with diet changes, exercise, weight management, and routine monitoring. it is not a substitute for healthy lifestyle measures, but rather an additional tool to help reach individualized glucose goals.

how to use

VYLDA D 5/100 Tablet should be taken exactly as directed by a healthcare professional. it is generally taken by mouth, with or without food, but the specific timing may depend on the prescribed product and the patient’s overall treatment plan. it is important to take it consistently at the same time each day so that blood sugar control remains stable. swallow the tablet whole with water unless your pharmacist or doctor gives different instructions. do not crush, split, or chew it unless the product is specifically designed to be altered in that way.

because this medicine affects blood sugar through two different pathways, regular monitoring is important. patients may need periodic blood glucose checks, and in many cases hemoglobin a1c testing is done to assess longer-term control. your clinician may also monitor kidney function, hydration status, and other laboratory values depending on your medical history. if you are ill, not eating normally, dehydrated, or scheduled for surgery or a procedure, ask your healthcare provider whether the medicine should be temporarily adjusted, since sglt2 inhibitors can increase certain risks during periods of stress or reduced intake.

it is also important to keep following the dietary and exercise plan recommended for diabetes. this medicine works best when combined with carbohydrate awareness, regular physical activity, and attention to body weight and cardiovascular risk factors. do not stop taking the medicine on your own even if you feel well, because blood sugar can rise again without obvious symptoms. if you experience repeated low blood sugar, unusual side effects, or signs of infection or dehydration, contact a healthcare professional promptly.

safety information

• warnings: VYLDA D 5/100 Tablet can cause important safety concerns that require attention. dapagliflozin may increase the risk of dehydration, low blood pressure, genital fungal infections, urinary tract infections, and in rare cases diabetic ketoacidosis even when blood sugar is not extremely high. seek urgent medical help if you develop nausea, vomiting, stomach pain, rapid breathing, unusual fatigue, confusion, or fruity-smelling breath, as these may be warning signs of ketoacidosis. vildagliptin has been associated with rare liver-related problems and should be used cautiously in people with liver disease or a history of abnormal liver tests.
• side effects: common side effects may include increased urination, thirst, mild dizziness, urinary discomfort, genital itching or discharge, nasopharyngitis-like symptoms, headache, nausea, or mild stomach upset. some people may experience low blood sugar, especially if this medicine is combined with insulin or a sulfonylurea. serious side effects, though less common, can include severe urinary tract infection, kidney function worsening, dehydration, severe allergic reactions, pancreatitis, liver injury, and diabetic ketoacidosis. any severe or persistent symptom should be evaluated by a healthcare professional.
• precautions: this medicine should be used carefully in people with kidney impairment, recurrent urinary or genital infections, low blood pressure, dehydration, older age, or those who take diuretics. it may not be suitable for people with type 1 diabetes, a history of diabetic ketoacidosis, severe liver disease, or significant kidney problems depending on current clinical guidance and the exact formulation. people scheduled for surgery, prolonged fasting, severe illness, or reduced food and fluid intake should inform their healthcare team because the medicine may need to be held temporarily to reduce risk.
• pregnancy/breastfeeding: the safety of VYLDA D 5/100 Tablet during pregnancy is not well established, and it is generally not preferred unless a healthcare professional determines that the benefits outweigh the risks. medicines that affect glucose handling may not be appropriate during pregnancy because insulin-based regimens are often better studied and more controllable. breastfeeding safety is also uncertain, so a doctor should be consulted before use while nursing.
• interactions: this medicine may interact with insulin and other diabetes drugs, increasing the chance of low blood sugar. diuretics can increase the risk of dehydration and low blood pressure when used with dapagliflozin. alcohol may worsen dehydration and can also complicate blood sugar control, especially if intake is heavy or unpredictable. certain medicines that affect kidney function, blood pressure, or liver enzymes may also require caution. always provide your healthcare provider with a complete list of prescription medicines, over-the-counter products, and herbal supplements.

additional information

• storage: store the tablets in a cool, dry place away from moisture, heat, and direct sunlight. keep the medicine in its original container or packaging if possible, and store it out of reach of children and pets. do not use tablets that are expired, damaged, or exposed to excessive moisture.
• missed dose: if you miss a dose, take it when you remember unless it is almost time for the next scheduled dose. if the next dose is near, skip the missed dose and continue with your regular schedule. do not take two doses at once to make up for a missed dose, as this may increase side effects.
• overdose: an overdose may lead to symptoms such as severe dizziness, dehydration, excessive urination, low blood sugar, nausea, vomiting, or signs of ketoacidosis. if an overdose is suspected, seek immediate medical help or contact poison control right away. emergency treatment may be needed, especially if the person is confused, weak, fainting, or having breathing problems.
• habit forming: no, this medicine is not considered habit forming. it does not cause addiction or dependence in the way some controlled medicines can. however, it should still be taken regularly as prescribed because stopping diabetes treatment can lead to poor blood sugar control and complications.

frequently asked questions

this information is for educational purposes only and should not be considered medical advice. always consult a qualified healthcare professional before use.